SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-138168
Filing Date
2020-05-11
Accepted
2020-05-11 06:31:38
Documents
53
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d900865d10q.htm 10-Q 337055
2 EX-31.1 d900865dex311.htm EX-31.1 11140
3 EX-31.2 d900865dex312.htm EX-31.2 11134
4 EX-32.1 d900865dex321.htm EX-32.1 4961
5 EX-32.2 d900865dex322.htm EX-32.2 4955
  Complete submission text file 0001193125-20-138168.txt   2487805

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT galt-20200331.xml EX-101.INS 340721
7 XBRL TAXONOMY EXTENSION SCHEMA galt-20200331.xsd EX-101.SCH 32399
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20200331_cal.xml EX-101.CAL 18770
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20200331_def.xml EX-101.DEF 227612
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20200331_lab.xml EX-101.LAB 273952
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20200331_pre.xml EX-101.PRE 256670
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 20862512
SIC: 2834 Pharmaceutical Preparations